A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy
Author:
Affiliation:
1. Montefiore Medical Center/Albert Einstein College of Medicine
2. Centers for Disease Control, Division of Viral Hepatitis
3. Prisma Health, University of South Carolina School of Medicine, Clemson University School of Health Research
Abstract
Funder
National Institute on Drug Abuse
Gilead Sciences
Albert Einstein College of Medicine, Yeshiva University
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Link
http://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiaa100/32985770/jiaa100.pdf
Reference45 articles.
1. Hepatitis C virus and liver transplantation;Verna;Clin Liver Dis,2006
2. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007;Ly;Ann Intern Med,2012
3. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States;Rein;Dig Liver Dis,2011
4. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression;Davis;Gastroenterology,2010
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study;International Journal of Drug Policy;2024-01
2. Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions;International Journal of Drug Policy;2021-10
3. Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens;Open Forum Infectious Diseases;2021-09-30
4. Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs;Viruses;2021-06-16
5. Elimination of hepatitis C among HIV-positive population in Asia: old and new challenges;Future Virology;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3